An increase in measured lean mass is not automatically an increase in functional muscle. Hydration is a particularly important competing explanation when edema develops during treatment. Primary study
What the report found
An eight-person randomized crossover study evaluated growth hormone, glutamine, and a high-carbohydrate, low-fat diet. Body weight and DXA lean mass increased during active treatment, but macronutrient and fluid absorption did not. All eight participants developed peripheral edema, and body weight returned to baseline within two weeks after stopping treatment. The author interpreted the apparent gain as likely reflecting extracellular fluid. Primary report
Our appraisal: measurement categories have boundaries
DXA partitions body composition into categories; it does not directly measure strength or count newly formed muscle fibers. Fluid shifts can affect the interpretation of a lean-tissue estimate. A favorable number therefore needs to be read alongside examination findings and the timing of reversal.
The edema observation is not merely an unrelated side effect. It is also evidence relevant to the meaning of the efficacy measurement. Harms and outcomes can interact in precisely this way.
A rapid return toward baseline after withdrawal further limits a durable tissue-growth interpretation. It does not prove the exact contribution of every compartment, but it makes an unqualified lasting-muscle-gain claim inappropriate.
The absence of improved absorption is another boundary. Changes in body composition cannot be treated as proof that the remaining bowel extracted more nutrients or that nutritional-support requirements fell.
This report should be reviewed together with the related intestinal-adaptation trial rather than automatically counted as a new independent cohort. Its distinctive contribution is the interpretation of body-composition measurements in the presence of fluid retention. Full review should reconcile participant lineage, scan timing, edema assessment, and the statistical comparisons before any quantitative summary. It does not support an anabolic or muscle-building recommendation.
Frequently asked questions
Did measured lean mass increase?
Yes.
Did every participant develop peripheral edema?
Yes, according to the report.
Was improved nutrient absorption demonstrated?
No.
Did body weight remain elevated after treatment stopped?
It returned to baseline within two weeks.
Is DXA lean mass identical to muscle strength?
No.
Can an adverse effect change interpretation of an efficacy measure?
Yes; fluid retention is relevant here.
What must be checked before counting this as replication?
Whether participants overlap with related reports.